Teza Capital Management LLC Royalty Pharma PLC Transaction History

Teza Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$27.46 - $31.33 $208,036 - $237,356	7,576 New	7,576 $230,000
Q3 2023 Feb 22, 2024	SELL	$26.26 - $31.38 $3,991 - $4,769	-152 Reduced 1.87%	7,995 $216,000
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $82,561 - $98,658	3,144 Added 23.46%	16,543 $448,000
Q2 2023 Feb 22, 2024	BUY	$29.6 - $36.56 $241,151 - $297,854	8,147 New	8,147 $250,000
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $151,404 - $187,004	5,115 Added 61.75%	13,399 $411,000
Q1 2023 May 15, 2023	SELL	$32.77 - $39.4 $409,919 - $492,854	-12,509 Reduced 60.16%	8,284 $298,000
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $814,461 - $915,723	20,793 New	20,793 $821,000
Q3 2021 Nov 10, 2021	SELL	$36.14 - $42.24 $197,360 - $230,672	-5,461 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$39.85 - $46.63 $217,620 - $254,646	5,461 New	5,461 $224,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Teza Capital Management LLC with notifications on news.